Durability Joseph W. (Jay) Cormier, PhD. Describes the animal, construct, and proposed claim Are there sequences that are likely to contain potential.

Slides:



Advertisements
Similar presentations
Fieldwork assessment The difference between AS and A2 David Redfern
Advertisements

Office of New Animal Drug Evaluation Laura L. Hungerford, DVM, MPH, PhD Senior Advisor, Science and Policy, ONADE Professor, University of Maryland School.
Determining the Significant Aspects
Complying with FSMA: What a cashew exporter to the U.S. needs to do.
Phenotypic Characterization Harlan Howard, PhD. Describes the animal, construct, and proposed claim Are there sequences that are likely to contain potential.
1 MANUFACTURING AND PRODUCTION OF BIOLOGICAL PRODUCTS (ERT 455) HAZARD ANALYSIS AND CRITICAL CONTROL POINT (HACCP) SYSTEM Munira Mohamed Nazari School.
Current Perspectives on Biotechnology: Projects and Future Challenges/Opportunities Jordan BeanDr. Jaimie Schnell Novel Foods SectionPlant Health and Biotechnology.
Food Safety Assessment Kevin Greenlees, PhD, DABT Kathleen Jones, PhD.
Regulatory Structure for GE Crops Alan McHughen, D.Phil., University of California Riverside, Ca USA
Jeff Jones, DVM, PhD Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S. Food and Drug Administration Regulation of Genetically.
1 REACh Registration, Evaluation and Authorization of Chemicals and Restriction! Ohio Valley SOT Wednesday, August 26, 2009 REACh: The New Toxicology Frontier.
COMPARABILITY PROTOCOLS ACPS March 12-13, 2003 Stephen K. Moore, Ph.D. Chemistry Team Leader CDER/Office of New Drug Chemistry Co-Chair, Comparability.
Environmental Safety Assessment Eric Silberhorn, PhD, DABT.
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
Background, Introduction, Statutory Authority, Introduction to Risk-Based Approach Larisa Rudenko, PhD, DABT.
INADs and Beginning the Review Process Larisa Rudenko, PhD, DABT.
Malini M. Wileman, PhD, RAC Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S. Food and Drug Administration Regulation of.
Mrs. Brandi Robinson Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulating Animal Drugs.
Listeria Summit - Washington, DC November RISK MANAGEMENT Current FSIS Activities Daniel Engeljohn, Ph.D. Office of Policy and Program Development.
Codex Guidelines for the Application of HACCP
Risk Assessment – An Essential Standard
Food safety and cheese International Food Safety Consultancy Dr.W.R. Marsman.
CVM’s Procedure for Setting Tolerances
BOOST YOUR EXPORTS WITH HACCP A PRACTICAL APPROACH TO IMPROVING EXPORTS WITH HACCP Michel Bayoud, MSOFHT, MRIPH President, CEO Boecker World Holding &
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
What is it? Why it is so important?
Market Food Vendor Meeting. License Types & Fees Single –Operates in conjunction with a single public event. –Valid for 30 days of continual operation.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Introduction to GMOs: Myths and realities Masami Takeuchi, Ph.D. Food Safety Officer.
Foreign Supplier Verification Programs Supplemental Proposal 1.
Proposed Rule for Preventive Controls for Animal Food.
Proposed Rule: 21 CFR 507 Proposed Rule for Preventive Controls for Animal Food 1.
Codex Science-based Approach to the Safety of Foods Derived from Modern Biotechnology James H. Maryanski, Ph.D. Food and Drug Administration Center for.
River Corridor Closure Project Safety People Results End State and Final Closure Jeff A Lerch Manager, Long Term Stewardship June 1 and 2, 2006.
HACCP Prepared By: Mrs. F. Malcolm-Hanson Date: 29 th November,2013 Group: 2 nd Year (Nutrition) Week: 12.
Sterile Drug Products Dr. Peter Cooney Associate Director for Microbiology Office of New Drug Chemistry Center for Drug Evaluation and Research.
Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S.
YMEP Environmental Training Overview of Training Program Four Modules: 1.USAID Environmental Guidelines Purpose and Overview 2.Environmental Screening.
8-2 Service Objectives: Food safety management systems Active managerial control Hazard Analysis Critical Control point (HACCP)
2006 Safety Groups Program Returning Safety Groups Firms Shelley Wall WSIB Safety Group Program Consultant.
Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S.
H azard A nalysis C ritical C ontrol P oint. HACCP : A systematic approach to the identification, evaluation, and control of food safety hazards. Hazard.
Questions to Committee about Potential Cancer Risk with Use of Topical Immunosuppressants (Calcineurin Inhibitors) Question 1: Messages about Risk A. Based.
OSHA Safety and Health Program Management Guidelines
United States Department of Agriculture Food Safety and Inspection Service Public Health-Related Performance Standards Currently Under Consideration for.
INTERNATIONAL SCIENCE AND ENGINEERING FAIR Rules and Guidelines 2016.
Low Power and Shutdown PSA IAEA Training Course on Safety Assessment of NPPs to Assist Decision Making Workshop Information IAEA Workshop City, Country.
Auditing Stress at Work Andy Smith. Why we should take stress seriously? Work-related stress accounts for over a third of all new incidences of occupational.
Genetic Engineering AG-ASB-8:The student describes and addresses the general public’s food safety and environmental concerns. E. Discusses examples of.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Office of Pipeline Safety Remedial Action Review Protocol Integrity Management Workshop July 23-24, 2002.
DEPARTMENT OF HEALTH CENTER FOR BIOLOGICS AND HUMAN SERVICESEVALUATION and RESEARCH AND HUMAN SERVICES EVALUATION and RESEARCH Update on OCTGT Guidance.
Abstract A step-wise or ‘tiered’ approach has been used as a rational procedure to conduct environmental risk assessments in many disciplines. The Technical.
It’s a food… It’s a drug… It’s AquAdvantage Salmon! Ricardo Carvajal Hyman, Phelps & McNamara, P.C st Annual Tulane.
September Background LACORS scheme published in 2004 to Address concerns about inconsistency of risking between authorities Rationalise existing.
Overview of Intervention Mapping
Strengthening the Medical Device Clinical Trial Enterprise
Overview of FDA’s Program for Reviewing New Food Contact Substances
Division of Cardiovascular Devices
EFSA Trusted science for safe food Guilhem de Sèze
THE SUPERFUND PROCESS Assessment and Listing
HAZARDOUS MATERIALS INITIAL RESPONSE REFRESHER
Challenges Sourcing Clean Label Ingredients
HACCP Essential Tool for Food Safety
The Hazard Analysis Critical Control Point
Regional Seminar for OIE National Focal Points on Animal Production Food Safety Importance of collaboration between the Veterinary Services and industry.
The Hazard Analysis Critical Control Point
Level 3 Certificate Supporting Teaching and Learning in Schools
12 Safe Maintenance Rules
GMOs Legislation in EU.
Presentation transcript:

Durability Joseph W. (Jay) Cormier, PhD

Describes the animal, construct, and proposed claim Are there sequences that are likely to contain potential hazards to the animal, humans, or animals consuming food from that animal, or the environment? e.g., does the construct contain mobilizable sequences from viruses that may be endemic in that species? Does the insertion of the rDNA construct pose a hazard to the animal, humans, other animals by feed, or the environment? What are the direct and indirect risks posed to the GE animal? (e.g., can surveying the health and other phenotypic characteristics of the animal inform us with respect to risk to the animal and potential human food safety concerns?) Are the genotype or phenotype changing over the product lifespan in a way that would affect the risks associated with the product? Is there a plan in place to monitor those changes? Durability What hazards/risks have been identified in the hierarchical review?

Why Prepare a Durability Assessment and Plan? Ensure that future animals are equivalent to those evaluated for safety and effectiveness during pre-market review Genotypic and Phenotypic Evaluation Durability Plan Sponsor’s Commitment

Genotypic and Phenotypic Evaluation Are there data to suggest that the animal’s genotype and phenotype are “stable”?

Durability Plan A plan to ensure that future animals are equivalent to today’s Or, if the animals are not equivalent, what procedures are in place to provide a remedy for the change or to reassess the risk of/to the new animal

Sponsor’s Commitment

Durability for GTC Durability Evaluation Multi-generation genotypic/phenotypic data assessment Characterization of construct in animal Animal safety assessment; product claim demonstration Durability Plan Sponsor-developed plan including Test methods, specifications, and validation Testing frequency, reporting of results Lineage replacement procedures Conclusion The demonstrated durability over 7 generations Plan ensures future consistency of the approved GE animal lineage